Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A.S. Kenkishvili
Observed name:
A. O. Kenkishvili
Institutions:
Pirogov Russian National Research Medical University,
Russian Medical Academy of Continuous Professional Education,
Ministry of Health of the Russian Federation
Observed institutions:
Pirogov Russian National Research Medical University,
Russian Medical Academy of Continuous Professional Education,
Ministry of Health of the Russian Federation
ORCID:
0009-0003-1254-1728
Observed ORCID:
0009-0003-1254-1728
OpenAlex ID:
A5136046994
Modern glucose-lowering drugs SGLT2 inhibitors and GLP-1 agonists in the prevention of cardiovascular disease and dementia in patients with diabetes and metabolic disorders
2026
·
E. N. Saykina
, A. O. Kenkishvili
, et al.
·
Terapevt (General Physician)
Comparative safety and efficacy of novel multi-action incretins in the treatment of obesity and type 2 diabetes: results of early studies
2026
·
A. O. Kenkishvili
, M. E. Arutyunyan
, et al.
·
Spravočnik vrača obŝej praktiki (Journal of Family Medicine)
Retatrutide: prospects and potential risks in oncology and ophthalmology
2026
·
A. O. Kenkishvili
, M. E. Arutyunyan
, et al.
·
Spravočnik vrača obŝej praktiki (Journal of Family Medicine)
Childhood obesity: on the issue of the efficacy and safety of modern weight loss medicines
2026
·
M. L. Maksimov
, A. V. Matveev
, et al.
Comparative analysis of safety profile of GLP-1 receptor agonists and dual-acting incretins in diabetes mellitus and obesity
2026
·
A.S. Kenkishvili
, G.S. Panova
, et al.
Safety and efficacy of the novel multi-agonist retatrutide in patients with diabetes and obesity. Results of initial studies
2026
·
A.S. Kenkishvili
, M.E. Arutyunyan
, et al.
Study of Quercetin Dihydrate Effects in a Model of Ova-induced Respiratory Allergy in Mice
2017
·
A. O. Kenkishvili
, D. Z. Albegova
, et al.
·
Medical Immunology (Russia)
PDF
Show more works
View as search
Works count:
7
Citation count:
H-index:
I10-index:
Year
Topic
Type